Physician profile
Michelle C Scanlan
NPI 1275534109
$3,030.99
in general payments reported to CMS, 2019-2025
16 companies · $669 in 2025
The $669 reported for 2025 was more than what 78% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $576 · 2020: $73.54 · 2021: $241 · 2022: $250 · 2023: $463 · 2024: $757 · 2025: $669.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,890.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,889.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,195.07 | 2020-2025 | Evenity, Repatha, Otezla |
| Novo Nordisk INC | $639.21 | 2019-2025 | Wegovy |
| Esperion Therapeutics, INC. | $236.85 | 2021-2024 | Nexletol, Nexlizet |
| Heartflow, INC. | $153.68 | 2025 | |
| Sanofi-Aventis U.S. LLC | $124.99 | 2019 | |
| Glaxosmithkline, LLC. | $121.82 | 2023 | Arexvy |
| Novartis Pharmaceuticals Corporation | $99.71 | 2024-2025 | |
| Amarin Pharma, INC. | $83.64 | 2019 | |
| Abbott Laboratories | $76.01 | 2022-2023 | Freestyle Libre 3 |
| Pfizer INC. | $71.95 | 2019-2024 | |
| Scilex Pharmaceuticals INC. | $64.43 | 2019 | |
| Abbvie INC. | $46.24 | 2022-2023 | Ubrelvy |
| Merck Sharp & Dohme LLC | $41.08 | 2020-2024 | Gardasil, Capvaxive, Gardasil 9 |
| Kaleo, INC. | $40.27 | 2019 | |
| Celgene Corporation | $18.67 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $17.37 | 2025 | Flexitouch Plus, Nimbl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Scanlan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.